regadenoson
Showing 1 - 25 of 100
Coronary Artery Disease, Myocardial Perfusion Abnormalities Trial in Rochester, Omaha (Regadenoson; Optison)
Completed
- Coronary Artery Disease
- Myocardial Perfusion Abnormalities
- Regadenoson; Optison
-
Rochester, Minnesota
- +1 more
Dec 6, 2022
Cardiac Function Trial in Westminster (regadenoson)
Completed
- Cardiac Function
- regadenoson
-
Westminster, MarylandUniversity of MD Cardiology Physicians
Jul 29, 2022
Myocardial Ischemia, Coronary Artery Disease Trial in Worldwide (Regadenoson)
Recruiting
- Myocardial Ischemia
- Coronary Artery Disease
- Regadenoson
-
Paris, France
- +4 more
Oct 7, 2022
Left Ventricular Systolic Dysfunction, Sudden Cardiac Death Trial in Birmingham (regadenoson)
Active, not recruiting
- Left Ventricular Systolic Dysfunction
- Sudden Cardiac Death
- regadenoson
-
Birmingham, AlabamaUAB
Mar 11, 2022
Ischemia Trial in Houston (Regadenoson)
Active, not recruiting
- Ischemia
- Regadenoson
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Feb 4, 2022
COVID-19, Lung Inflammation Trial in Baltimore (Regadenoson, Placebo Control)
Recruiting
- COVID-19
- Lung Inflammation
- Regadenoson
- Placebo Control
-
Baltimore, MarylandUniversity of Maryland Medical Center
Jan 21, 2022
Coronary Artery Disease Trial in Chicago (ASSUAGE Protocol)
Withdrawn
- Coronary Artery Disease
- ASSUAGE Protocol
-
Chicago, IllinoisRush University Medical Center
Oct 4, 2021
Lung Transplant Trial in Baltimore, Cleveland (Regadenoson, Placebo)
Recruiting
- Lung Transplant
- Regadenoson
- Placebo
-
Baltimore, Maryland
- +1 more
Sep 27, 2021
Coronary Artery Disease Trial in Pittsburgh (SPECT imaging)
Terminated
- Coronary Artery Disease
- SPECT imaging
-
Pittsburgh, PennsylvaniaUPMC Presbyterian Hospital
Jan 4, 2022
Sickle Cell Disease Trial in Memphis ([13N]NH3, Lexiscan, Positron emission tomography)
Not yet recruiting
- Sickle Cell Disease
- [13N]NH3
- +2 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jan 11, 2023
Coronary Artery Disease Trial in Atlanta (PET-MPI Protocol, CT-MPI, CT-FFR)
Recruiting
- Coronary Artery Disease
- PET-MPI Protocol
- +3 more
-
Atlanta, GeorgiaEmory University Hospital
Jul 6, 2022
Pulmonary Hypertension Trial in Denver (Regadenoson)
Terminated
- Pulmonary Hypertension
- Regadenoson
-
Denver, ColoradoNational Jewish Health
Jan 15, 2021
Heart Transplant Failure and Rejection Trial in La Jolla (Regadenoson)
Recruiting
- Heart Transplant Failure and Rejection
- Regadenoson
-
La Jolla, CaliforniaUC San Diego
Nov 3, 2021
Quantitative 13N-Ammonia Cardiac Rest/Stress Digital PET/CT
Completed
- Coronary Artery Disease
- Cardiac Perfusion Rest/Stress Digital PET/CT
- +2 more
-
Stanford, CaliforniaStanford University
Oct 24, 2021
Arm Exercise Versus Pharmacologic Stress Testing for Clinical
Terminated
- Veterans Referred to the St. Louis VAMC Stress Tes
- Regadenoson myocardial perfusion imaging stress test
- +3 more
-
Saint Louis, MissouriSt. Louis VA Medical Center John Cochran Division, St. Louis, MO
Feb 16, 2022
Coronary Artery Disease Trial in Chicago (Regadenoson)
Completed
- Coronary Artery Disease
- Regadenoson
-
Chicago, IllinoisUniversity of Chicago Medical Center
Feb 17, 2021
Coronary Disease Trial in Chicago (regadenoson)
Completed
- Coronary Disease
- regadenoson
-
Chicago, IllinoisUniversity of Chicago
Jul 8, 2021
Sickle Cell Disease, Sickle Cell Anemia Trial in Chicago, Milwaukee (regadenoson infusion with contrast-enhanced ultrasound,
Active, not recruiting
- Sickle Cell Disease
- Sickle Cell Anemia
- regadenoson infusion with contrast-enhanced ultrasound
- contrast-enhanced ultrasound
-
Chicago, Illinois
- +1 more
Oct 20, 2020
Lung Transplant Trial in Baltimore, Charlottesville (Regadenoson infusion)
Unknown status
- Lung Transplant
- Regadenoson infusion
-
Baltimore, Maryland
- +1 more
Jun 3, 2020
Microvascular Coronary Artery Disease Trial in Worldwide (SAR407899, Placebo, Adenosine)
Terminated
- Microvascular Coronary Artery Disease
- SAR407899
- +5 more
-
Los Angeles, California
- +9 more
Mar 15, 2022
Heart Failure, Diastolic, Diastolic Heart Failure, Hypertension Trial in Nashville (regadenoson)
Completed
- Heart Failure, Diastolic
- +2 more
- regadenoson
-
Nashville, TennesseeVanderbilt University Medical Center
Feb 1, 2021
Whole-Heart Myocardial Blood Flow Quantification Using MRI
Recruiting
- Coronary Artery Disease
- Coronary Microvascular Disease
- Myocardial Perfusion Cardiac MRI.
- +2 more
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Jan 25, 2021
MRI Scans Trial in Salt Lake City (Adenosine, Regadenoson, O-15 labeled radioactive water)
Recruiting
- MRI Scans
- Adenosine
- +4 more
-
Salt Lake City, Utahuniversity of Utah, Radiology Research
Oct 21, 2020
Hypertrophic Cardiomyopathy, Non-ischemic Dilated Cardiomyopathy, Microvascular Ischaemia of Myocardium Trial in Durham
Terminated
- Hypertrophic Cardiomyopathy
- +2 more
- Regadenoson
- Adenosine
-
Durham, North CarolinaDuke Cardiovascular Magnetic Resonance Center
Aug 26, 2020
MRI Scans Trial in Salt Lake City (Adenosine, Regadenoson, O-15 labeled radioactive water)
Withdrawn
- MRI Scans
- Adenosine
- +4 more
-
Salt Lake City, UtahUniversity of Utah, Radiology Research
Sep 9, 2020